🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 15 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/12/1998 | 42,58 | 43,75 | 41,64 | 43,04 | +1,10% | 4,94% | 83.142 |
| 07/12/1998 | 39,77 | 42,58 | 39,30 | 42,58 | +7,06% | 8,24% | 77.585 |
| 04/12/1998 | 37,90 | 39,77 | 37,43 | 39,77 | +6,25% | 6,17% | 29.976 |
| 03/12/1998 | 39,30 | 40,24 | 37,43 | 37,43 | -4,76% | 7,14% | 73.845 |
| 02/12/1998 | 38,37 | 39,30 | 37,43 | 39,30 | +3,70% | 4,88% | 70.372 |
| 01/12/1998 | 39,07 | 39,30 | 37,43 | 37,90 | +1,89% | 4,79% | 61.341 |
| 30/11/1998 | 38,13 | 38,37 | 36,96 | 37,20 | -2,45% | 3,68% | 47.769 |
| 27/11/1998 | 37,66 | 38,37 | 37,66 | 38,13 | +0,62% | 1,86% | 32.434 |
| 25/11/1998 | 37,66 | 38,37 | 37,20 | 37,90 | +2,53% | 3,11% | 45.792 |
| 24/11/1998 | 36,96 | 37,90 | 36,96 | 36,96 | -2,47% | 2,53% | 30.751 |
| 23/11/1998 | 37,20 | 38,37 | 36,73 | 37,90 | +1,25% | 4,40% | 55.090 |
| 20/11/1998 | 36,96 | 38,37 | 36,49 | 37,43 | +1,91% | 5,06% | 78.253 |
| 19/11/1998 | 37,43 | 37,66 | 36,49 | 36,73 | -1,87% | 3,13% | 50.895 |
| 18/11/1998 | 39,77 | 39,77 | 36,96 | 37,43 | -4,76% | 7,06% | 36.014 |
| 17/11/1998 | 38,37 | 39,30 | 35,56 | 39,30 | -1,18% | 9,76% | 125.381 |
| 16/11/1998 | 43,51 | 44,45 | 36,49 | 39,77 | -5,56% | 18,28% | 116.645 |
| 13/11/1998 | 39,77 | 43,04 | 39,77 | 42,11 | +5,88% | 8,24% | 69.784 |
| 12/11/1998 | 40,70 | 41,64 | 39,30 | 39,77 | -3,41% | 5,75% | 160.941 |
| 11/11/1998 | 41,41 | 42,11 | 40,94 | 41,17 | +1,73% | 2,82% | 65.082 |
| 10/11/1998 | 43,28 | 43,51 | 40,24 | 40,47 | -7,49% | 7,57% | 159.178 |
| 09/11/1998 | 45,38 | 45,38 | 43,04 | 43,75 | -2,60% | 5,15% | 76.169 |
| 06/11/1998 | 44,45 | 45,38 | 43,98 | 44,92 | +0,00% | 3,16% | 74.860 |
| 05/11/1998 | 44,92 | 44,92 | 44,21 | 44,92 | +0,00% | 1,56% | 35.880 |
| 04/11/1998 | 45,38 | 46,32 | 43,51 | 44,92 | +2,13% | 6,19% | 122.042 |
| 03/11/1998 | 43,04 | 45,85 | 41,87 | 43,98 | +2,73% | 9,24% | 113.359 |
| 02/11/1998 | 40,94 | 43,04 | 40,94 | 42,81 | +5,17% | 5,14% | 102.645 |
| 30/10/1998 | 41,17 | 41,64 | 40,24 | 40,70 | -1,14% | 3,41% | 40.529 |
| 29/10/1998 | 39,07 | 41,64 | 39,07 | 41,17 | +2,33% | 6,59% | 45.392 |
| 28/10/1998 | 40,24 | 40,24 | 38,37 | 40,24 | +3,61% | 4,65% | 38.926 |
| 27/10/1998 | 41,17 | 42,58 | 38,83 | 38,83 | -5,68% | 9,09% | 128.480 |